CHD1 deletion stabilizes HIF1α to promote angiogenesis and glycolysis in prostate cancer
Asian Journal of Andrology · 2023-03 · 25 (2) · 152-157
DOI: 10.4103/aja202287 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Journal of Andrology, online erschienen am 10.01.2023. Verfasst von Yu-Zhao Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China. Hauptthemen laut MEDLINE: Von Hippel-Lindau Tumor Suppressor Protein, Prostatic Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Chromodomain-helicase-DNA-binding protein 1 ( CHD1 ) deletion is among the most common mutations in prostate cancer (PCa), but its role remains unclear. In this study, RNA sequencing was conducted in PCa cells after clustered regularly interspaced palindromic repeat (CRISPR)/CRISPR-associated protein 9 (Cas9)-based CHD1 knockout. Gene set enrichment analysis (GSEA) indicated upregulation of hypoxia-related pathways. A subsequent study confirmed that CHD1 deletion significantly upregulated hypoxia-inducible factor 1α (HIF1α) expression. Mechanistic investigation revealed that CHD1 deletion upregulated HIF1α by transcriptionally downregulating prolyl hydroxylase domain protein 2 (PHD2), a prolyl hydroxylase catalyzing the hydroxylation of HIF1α and thus promoting its degradation by the E3 ligase von Hippel–Lindau tumor suppressor (VHL). Functional analysis showed that CHD1 deletion promoted angiogenesis and glycolysis, possibly through HIF1α target genes. Taken together, these findings indicate that CHD1 deletion enhances HIF1α expression through PHD2 downregulation and therefore promotes angiogenesis and metabolic reprogramming in PCa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
- Oncology Research Laboratory, Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, Xi'an 710061, China.
Zitieren
APA
Wang, Y. Z., Qian, Y. C., Yang, W. J., Ye, L. H., Guo, G. D., Lv, W., Huan, M. X., Feng, X. Y., Wang, K., Yang, Z., Gao, Y., Li, L., & Chen, Y. L. (2023). CHD1 deletion stabilizes HIF1α to promote angiogenesis and glycolysis in prostate cancer. Asian Journal of Andrology, 25(2), 152-157. https://doi.org/10.4103/aja202287
Vancouver
Wang YZ, Qian YC, Yang WJ, Ye LH, Guo GD, Lv W, et al. CHD1 deletion stabilizes HIF1α to promote angiogenesis and glycolysis in prostate cancer. Asian Journal of Andrology. 2023;25(2):152-157. doi:10.4103/aja202287
BibTeX
@article{Wang2023,
author = {Wang, Yu-Zhao and Qian, Yu-Chen and Yang, Wen-Jie and Ye, Lei-Hong and Guo, Guo-Dong and Lv, Wei and Huan, Meng-Xi and Feng, Xiao-Yu and Wang, Ke and Yang, Zhao and Gao, Yang and Li, Lei and Chen, Yu-Le},
title = {CHD1 deletion stabilizes HIF1α to promote angiogenesis and glycolysis in prostate cancer},
journal = {Asian Journal of Andrology},
year = {2023},
volume = {25},
number = {2},
pages = {152--157},
doi = {10.4103/aja202287}
}
EUVIMED